Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Juan M. Romero Acuna"'
Autor:
S. Amato, Juan M. Romero Acuna, Luis Flores Acosta, Eduardo H. Ortiz, A Romero, M Machiavelli, Maria Ester Dominguez, Nora Marrone, Hebe Margot Fasce, M. J. Langhi, Carlos Teodoro Vallejo, Luis A. Romero Acuña, J E Perez, Fabrina Bologna, J. A. Lacava, Bernardo Amadeo Leone
Publikováno v:
American Journal of Clinical Oncology. 25:383-387
A phase II trial was performed to evaluate the efficacy and toxicity of the novel combination of vinorelbine and paclitaxel as first-line chemotherapy in patients with stages IIIB and IV non-small-cell lung cancer. From January 1997 to September 1999
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faf5458bda3e035d963e8700220a40d3
https://doi.org/10.1097/00000421-200208000-00013
https://doi.org/10.1097/00000421-200208000-00013
Biochemical Modulation of 5-Fluorouracil by Methotrexate in Patients With Advanced Gastric Carcinoma
Autor:
Eduardo H. Ortiz, J E Perez, R. Rodriguez, Bernardo Amadeo Leone, Carlos Teodoro Vallejo, M. R. Barbieri, Luis A. Romero Acuña, Maria Ester Dominguez, M Machiavelli, A Romero, J. A. Lacava, Juan M. Romero Acuna, M. J. Langhi
Publikováno v:
American Journal of Clinical Oncology. 21:452-457
A phase II trial was conducted to evaluate the efficacy and toxicity of a modulation of 5-fluorouracil (5-FU) by methotrexate (MTX) (with leucovorin (LV) rescue) as first-line chemotherapy in patients with locally advanced (inoperable) or metastatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb98186232e694e039349aad660bf030
https://doi.org/10.1097/00000421-199810000-00006
https://doi.org/10.1097/00000421-199810000-00006
Autor:
Luis A. Romero Acuña, Maria Ester Dominguez, A Romero, M. J. Langhi, M. R. Barbieri, M Machiavelli, Mirna Scenna, Focaccia G, J E Perez, Carlos Teodoro Vallejo, J. A. Lacava, Eduardo H. Ortiz, R. Rodriguez, Sergio Grasso, Bernardo Amadeo Leone, Guillermo Suttora, Juan M. Romero Acuna, S. Amato, José M. Boughen
Publikováno v:
American journal of clinical oncology. 23(5)
A phase II trial was performed to assess the efficacy and toxicity of a combination of ifosfamide (IFX), cisplatin (CDDP), and vinorelbine (VNB) as neoadjuvant chemotherapy (NAC) for untreated advanced cervical carcinoma (ACC). Between October 1995 a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f0e8f03ecd41fd0f0b176743a00649d
https://pubmed.ncbi.nlm.nih.gov/11039508
https://pubmed.ncbi.nlm.nih.gov/11039508